Anne Cossmann

3.1k total citations · 2 hit papers
27 papers, 912 citations indexed

About

Anne Cossmann is a scholar working on Infectious Diseases, Clinical Psychology and Neurology. According to data from OpenAlex, Anne Cossmann has authored 27 papers receiving a total of 912 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Infectious Diseases, 6 papers in Clinical Psychology and 5 papers in Neurology. Recurrent topics in Anne Cossmann's work include SARS-CoV-2 and COVID-19 Research (20 papers), COVID-19 Clinical Research Studies (13 papers) and COVID-19 and Mental Health (5 papers). Anne Cossmann is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (20 papers), COVID-19 Clinical Research Studies (13 papers) and COVID-19 and Mental Health (5 papers). Anne Cossmann collaborates with scholars based in Germany, Australia and Romania. Anne Cossmann's co-authors include Georg M. N. Behrens, Alexandra Dopfer‐Jablonka, Luise Graichen, Stefan Pöhlmann, Amy Kempf, Markus Hoffmann, Hans‐Martin Jäck, Sebastian Schulz, Inga Nehlmeier and Anna-Sophie Moldenhauer and has published in prestigious journals such as Cell, Nature Communications and International Journal of Molecular Sciences.

In The Last Decade

Anne Cossmann

26 papers receiving 907 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic

2021 557 citations Markus Hoffmann, Nadine Krüger et al. profile →
SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency

2024 49 citations Lu Zhang, Amy Kempf et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anne Cossmann Germany	12	795	167	96	92	88	27	912
Anna-Sophie Moldenhauer Germany	12	873 1.1×	221 1.3×	81 0.8×	112 1.2×	140 1.6×	14	1.0k
Maegan L. Sheehan United States	6	663 0.8×	154 0.9×	58 0.6×	81 0.9×	100 1.1×	9	727
Katie E. Flight United Kingdom	6	658 0.8×	183 1.1×	90 0.9×	71 0.8×	147 1.7×	7	942
Martin Lier Germany	5	533 0.7×	134 0.8×	54 0.6×	64 0.7×	66 0.8×	8	607
Katherine McMahan United States	11	502 0.6×	128 0.8×	67 0.7×	55 0.6×	160 1.8×	16	646
Alina Seidel Germany	8	679 0.9×	146 0.9×	46 0.5×	109 1.2×	78 0.9×	12	736
Minnan Yang China	7	949 1.2×	218 1.3×	82 0.9×	115 1.3×	137 1.6×	8	1.2k
Kaiming Tao United States	8	710 0.9×	237 1.4×	65 0.7×	63 0.7×	52 0.6×	13	863
Carina C. D. Joe United Kingdom	5	728 0.9×	110 0.7×	90 0.9×	69 0.8×	120 1.4×	9	878

Countries citing papers authored by Anne Cossmann

Since Specialization

Citations

This map shows the geographic impact of Anne Cossmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Cossmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Cossmann more than expected).

Fields of papers citing papers by Anne Cossmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Cossmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Cossmann. The network helps show where Anne Cossmann may publish in the future.

Co-authorship network of co-authors of Anne Cossmann

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Cossmann. A scholar is included among the top collaborators of Anne Cossmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Cossmann. Anne Cossmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cossmann, Anne, Metodi V. Stankov, Frank Klawonn, et al.. (2025). Impaired Hepatitis B and COVID-19 vaccination responses show strong concordance in hemodialysis patients with end stage renal disease. European journal of medical research. 30(1). 34–34.

Zhang, Lu, Alexandra Dopfer‐Jablonka, Inga Nehlmeier, et al.. (2024). Virological Traits of the SARS-CoV-2 BA.2.87.1 Lineage. Vaccines. 12(5). 487–487. 2 indexed citations

Kuhlmann, Ellen, Marius‐Ionuț Ungureanu, Georg M. N. Behrens, et al.. (2023). Migrant healthcare workers during COVID-19: bringing an intersectional health system-related approach into pandemic protection. A German case study. Frontiers in Public Health. 11. 1152862–1152862. 1 indexed citations

Barros‐Martins, Joana, Swantje I. Hammerschmidt, Gema Morillas Ramos, et al.. (2023). Omicron infection-associated T- and B-cell immunity in antigen-naive and triple-COVID-19-vaccinated individuals. Frontiers in Immunology. 14. 1166589–1166589. 5 indexed citations

Mikuteit, Marie, Stephanie Heinemann, Dominik Schröder, et al.. (2022). Long-term Consequences of COVID-19 and the Pandemic: Protocol for a Web-Based, Longitudinal Observational Study (DEFEAT). JMIR Research Protocols. 11(10). e38718–e38718. 12 indexed citations

Mikuteit, Marie, Anne Cossmann, Ralf Gutzmer, et al.. (2022). Immunogenicity of COVID-19 Vaccination in Melanoma Patients under Immune Checkpoint Blockade. Oncology. 100(7). 392–398. 6 indexed citations

Sidarovich, Anzhalika, Nadine Krüger, Cheila Rocha, et al.. (2022). Host Cell Entry and Neutralization Sensitivity of SARS-CoV-2 Lineages B.1.620 and R.1. Viruses. 14(11). 2475–2475. 1 indexed citations

Arora, Prerna, Lu Zhang, Cheila Rocha, et al.. (2022). The SARS-CoV-2 Delta-Omicron Recombinant Lineage (XD) Exhibits Immune-Escape Properties Similar to the Omicron (BA.1) Variant. International Journal of Molecular Sciences. 23(22). 14057–14057. 4 indexed citations

Becker, Matthias, Anne Cossmann, Daniel Junker, et al.. (2022). Longitudinal cellular and humoral immune responses after triple BNT162b2 and fourth full-dose mRNA-1273 vaccination in haemodialysis patients. Frontiers in Immunology. 13. 1004045–1004045. 11 indexed citations

10.

Dulovic, Alex, Monika Strengert, Gema Morillas Ramos, et al.. (2022). Diminishing Immune Responses against Variants of Concern in Dialysis Patients 4 Months after SARS-CoV-2 mRNA Vaccination. Emerging infectious diseases. 28(4). 743–750. 13 indexed citations

11.

Schröder, Dominik, Frank Müller, Eva Hummers, et al.. (2022). The Impact of COVID-19 Vaccination on the Social Participation of Immunocompromised Persons – Results of a Multicenter Observational Study. Frontiers in Public Health. 10. 877623–877623. 5 indexed citations

12.

Odak, Ivan, Christian Schultze‐Florey, Swantje I. Hammerschmidt, et al.. (2022). Longitudinal Tracking of Immune Responses in COVID-19 Convalescents Reveals Absence of Neutralization Activity Against Omicron and Staggered Impairment to Other SARS-CoV-2 Variants of Concern. Frontiers in Immunology. 13. 863039–863039. 6 indexed citations

13.

Dopfer‐Jablonka, Alexandra, Sandra Steffens, Frank Müller, et al.. (2022). SARS-CoV-2-specific immune responses in elderly and immunosuppressed participants and patients with hematologic disease or checkpoint inhibition in solid tumors: study protocol of the prospective, observational CoCo immune study. BMC Infectious Diseases. 22(1). 403–403. 9 indexed citations

14.

Arora, Prerna, Amy Kempf, Inga Nehlmeier, et al.. (2022). SARS-CoV-2 variants C.1.2 and B.1.621 (Mu) partially evade neutralization by antibodies elicited upon infection or vaccination. Cell Reports. 39(5). 110754–110754. 4 indexed citations

15.

Strengert, Monika, Matthias Becker, Gema Morillas Ramos, et al.. (2021). Cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine in patients on haemodialysis. EBioMedicine. 70. 103524–103524. 44 indexed citations

16.

Stankov, Metodi V., Anne Cossmann, Alexandra Dopfer‐Jablonka, et al.. (2021). Humoral immune response following prime and boost BNT162b2 vaccination in people living with HIV on antiretroviral therapy. HIV Medicine. 23(5). 558–563. 39 indexed citations

17.

Arora, Prerna, Cheila Rocha, Amy Kempf, et al.. (2021). The spike protein of SARS-CoV-2 variant A.30 is heavily mutated and evades vaccine-induced antibodies with high efficiency. Cellular and Molecular Immunology. 18(12). 2673–2675. 29 indexed citations

18.

Bonifacius, Agnes, Anne Cossmann, Metodi V. Stankov, et al.. (2021). Long-Lasting Immunity Against SARS-CoV-2: Dream or Reality?. Frontiers in Medicine. 8. 770381–770381. 13 indexed citations

19.

Mielke, G., Torsten Witte, Kirsten Hoeper, et al.. (2021). Versorgung von rheumatologischen Patienten während des Lockdowns im Frühjahr 2020. Zeitschrift für Rheumatologie. 81(2). 157–163. 4 indexed citations

20.

Behrens, Georg M. N., Anne Cossmann, Metodi V. Stankov, et al.. (2020). Perceived versus proven SARS-CoV-2-specific immune responses in health-care professionals. Infection. 48(4). 631–634. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact